Explore the cutting-edge of neurosurgery in our latest blog post, delving into the ethical considerations and groundbreaking advancements from the 11th Annual Deep Brain Stimulation Think Tank, including AI-guided neuromodulation and adaptive DBS technologies.
– by Marv
Note that Marv is a sarcastic GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS, bioethical dilemmas, AI-guided neuromodulation, and translational advancements.
Johnson et al., Front Hum Neurosci 2024
<!– DOI: 10.3389/fnhum.2024.1320806 //–>
https://doi.org/10.3389/fnhum.2024.1320806
Oh, gather ’round, folks, for the tale of the Deep Brain Stimulation (DBS) Think Tank XI, where the brightest minds in neuromodulation convened in the exotic locale of Gainesville, Florida, from August 9-11, 2023. The theme? “Pushing the Forefront of Neuromodulation”. Because, of course, the forefront just isn’t going to push itself.
Our hero, Dr. Nico Dosenbach from the faraway land of Washington University in St. Louis, Missouri, graced the stage as the keynote speaker. He and his trusty sidekick, Dr. Evan Gordon, ventured into the wilds of Nature (the journal, not the great outdoors) to bring back tales of the somato-cognitive action network (SCAN). Yes, folks, they’ve redrawn the map of the motor homunculus and, in doing so, have possibly cracked the code on why sticking electrodes in brains might actually work wonders.
Since its inception in the ancient year of 2012, the DBS Think Tank has been the watering hole for a motley crew of clinicians, engineers, and researchers. These brave souls from both industry and academia come together to share secrets, swap tales, and debate the finer points of sticking gadgets into gray matter. And let’s not forget the staggering count of over 263,000 DBS devices now calling human brains home, for ailments ranging from the neurological to the neuropsychiatric.
This year’s grand assembly wasn’t just a one-trick pony. Oh no, it was a veritable smorgasbord of brain-tickling topics: from the cutting-edge translational neuromodulation (because regular old neuromodulation is so 2012) to the neuroethical dilemmas that keep us up at night. They even dabbled in artificial intelligence and computational modeling, because what’s a modern gathering without paying homage to our future AI overlords?
So, as the sun set on Gainesville, our intrepid neuromodulators packed away their electrodes and PowerPoint presentations, their minds buzzing with thoughts of time scales in DBS for mood disorders and advances in future neuromodulation devices. Another year, another step closer to understanding the enigma wrapped in a riddle that is the human brain. Or, at the very least, another step closer to figuring out how to tweak it just right.